Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

caregiving

Scientist

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

Cuttsy + Cuttsy

- PMLiVE

Doctored Truths

When the truth is doctored, lives hang in the balance.

Havas Lynx

- PMLiVE

Climate of Health

What’s happening to our planet is having an undeniable and devastating impact across every aspect of human health. What harms the world, harms us all. And these effects are so...

Havas Lynx

- PMLiVE

Passion and Pain: Millennial HCP Report

When we investigate millennial healthcare professionals (HCPs), we see a generation experiencing a clash of two existences. On one hand, harness their passion and it’s like bottling lightening.  On the other, a more sobering story...

Havas Lynx

- PMLiVE

Health for All

Stories matter. They bind people together, create a sense of connection, and engage our thoughts, emotions, and imagination all at once. They show us other people’s perspectives and let us...

Havas Lynx

- PMLiVE

Bristol Myers Squibb evolves and expands multiple myeloma programme

Created in 2016, the Standing in the Gaap programme aims to advance more equitable care

- PMLiVE

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

Inizio

- PMLiVE

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Inizio

- PMLiVE

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.

Inizio

- PMLiVE

One-carbon Therapeutics collaborates with Tempus in cancer treatment

The treatment is currently being evaluated in a phase 1/2 multicentre clinical study

- PMLiVE

Lilly to acquire Centessa in deal worth up to $7.8bn

The companies aim to advance treatments for narcolepsy and other sleep-wake disorders

- PMLiVE

Takeda’s CEO-elect, Julie Kim, proposed as new candidate for Board of Directors

The company has also proposed new candidates for director appointments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links